Evidence map›Paper›PMID 37393538›Full record

ArticleThe British journal of radiology2023

The usefulness of machine-learning-based evaluation of clinical and pretreatment

Masatoyo Nakajo, Hiromi Nagano, Megumi Jinguji, Yoshiki Kamimura, Keiko Masuda, Koji Takumi, Atsushi Tani, Daisuke Hirahara, Keisuke Kariya, Masaru Yamashita and 1 more

Open access · greenAbstract read
In one paragraph

Article in The British journal of radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Radiomics in laryngeal squamous cell carcinoma: state of the art.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Concomitant laryngeal squamous cell carcinoma and prostate cancer onEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  7. Article
  8. Role ofCancers · 2024
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Masatoyo NakajoDepartment of Radiology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Hiromi NaganoDepartment of Otolaryngology Head and Neck Surgery, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Megumi JingujiDepartment of Radiology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Yoshiki KamimuraDepartment of Radiology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Keiko MasudaDepartment of Radiology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Koji TakumiDepartment of Radiology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Atsushi TaniDepartment of Radiology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Daisuke HiraharaDepartment of Management Planning Division, Harada Academy, Kagoshima, Japan.
Keisuke KariyaDepartment of Radiology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Masaru YamashitaDepartment of Otolaryngology Head and Neck Surgery, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Takashi YoshiuraDepartment of Radiology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Kagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine whether machine learning (ML) analyses involving clinical and

methodsThis retrospective study included 49 patients with laryngeal cancer who underwent

resultsTumor size, T stage, N stage, GLZLM_ZLNU, and GLCM_Entropy were the five most important features for predicting disease progression.In both cohorts, the naïve Bayes model constructed by these five features was the best performing classifier (training: AUC = 0.805; testing: AUC = 0.842). The RSF model using the five features (tumor size, GLZLM_ZLNU, GLCM_Entropy, GLRLM_LRHGE and GLRLM_SRHGE) exhibited the highest performance in predicting PFS (training: C-index = 0.840; testing: C-index = 0.808).

conclusionML analyses involving clinical and ADVANCES IN KNOWLEDGE: ML approach using clinical and

Indexed as

Fluorodeoxyglucose F18Laryngeal NeoplasmsBayes TheoremDisease ProgressionHumansMachine LearningPositron Emission Tomography Computed TomographyPrognosisRetrospective StudiesFluorodeoxyglucose F18

Identifiers

PMID37393538
PMCPMC10461278
OpenAlexW4382881402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.